MPI Reasearch Invests in Upgrades and Department Expansions

February 11, 2016
Pharmaceutical Technology Editors

PTSM: Pharmaceutical Technology Sourcing and Management

MPI Research plans to renovate more than 55,000 square feet of facility space as part of the company’s plan to invest in upgrades and department expansion.

MPI Research, an early-stage drug development contract research organization (CRO) based in Michigan, is investing more than $5 million in a facility renovation to begin in 2016. The company plans to renovate more than 55,000 square feet of facility space.

Ed Amat, executive vice-president of global sales and marketing, says in a press announcement that the expansion reflects the increasing demand for investigational and preclinical pharmaceutical and medical device studies. Amat also says that MPI plans to renovate the company’s clinical pathology lab.

In the upcoming year, MPI hopes to increase the company’s workforce by approximately 10%. The company also plans to expand its surgical department with upgraded suites and additional equipment capabilities.

Source: MPI 

Related Content:

PharmTech News | Supplier News